Chinese

House Select Committee Tours Ginkgo Bioworks, Previews Biofab1, Ginkgo's New Integrated Data Generation Facility Set to Launch in 2025

Retrieved on: 
Tuesday, February 13, 2024

Ginkgo provided a tour of its expansive facility and discussed its unique position as a provider of services that facilitate applications of biotechnology in companies of all sizes across the economy.

Key Points: 
  • Ginkgo provided a tour of its expansive facility and discussed its unique position as a provider of services that facilitate applications of biotechnology in companies of all sizes across the economy.
  • Biofab1 is expected to begin operations early next year and aims to significantly increase Ginkgo's capacity to generate biological data.
  • Last summer, Ginkgo announced a strategic partnership with Google Cloud aimed at leveraging Ginkgo's Foundry and large biological data assets to develop new, state-of-the-art LLMs.
  • Ginkgo leadership shared with the visiting Committee its view that, like in other AI applications, leadership in the bioeconomy will necessitate leading in the development of these AI models.

MoneyHero Group Announces Resignation of Chief Financial Officer

Retrieved on: 
Thursday, February 8, 2024

SINGAPORE, Feb. 08, 2024 (GLOBE NEWSWIRE) -- MoneyHero Limited (Nasdaq: MNY ) (“MoneyHero” or the “Company”), a market leading personal finance aggregation and comparison platform in Greater Southeast Asia, today announced the resignation of Shaun Kraft, the Company’s Chief Financial Officer (“CFO”) and Chief Operating Officer (“COO”), effective May 4, 2024.

Key Points: 
  • SINGAPORE, Feb. 08, 2024 (GLOBE NEWSWIRE) -- MoneyHero Limited (Nasdaq: MNY ) (“MoneyHero” or the “Company”), a market leading personal finance aggregation and comparison platform in Greater Southeast Asia, today announced the resignation of Shaun Kraft, the Company’s Chief Financial Officer (“CFO”) and Chief Operating Officer (“COO”), effective May 4, 2024.
  • Following his departure, Mr. Kraft will remain available to MoneyHero in an advisory capacity to further support the transition of his role and responsibilities.
  • “On behalf of everyone at MoneyHero, I want to thank Shaun for his many contributions to the Company,” said Prashant Aggarwal, Chief Executive Officer of MoneyHero.
  • “During his eight-plus years here, Shaun helped transform MoneyHero into a dominant market leader, as well as a U.S. publicly traded company.

2025 KIA CARNIVAL MPV REDEFINED: ELEVATING MULTI-PURPOSE APPEAL WITH HYBRID POWER, SOPHISTICATED DESIGN ENHANCEMENTS AND ALLURING NEXT-GEN TECH

Retrieved on: 
Thursday, February 8, 2024

Brimming with Kia's next-generation of connected car technology, the Carnival steps into the digital age with connectivity and convenience at its core.

Key Points: 
  • Brimming with Kia's next-generation of connected car technology, the Carnival steps into the digital age with connectivity and convenience at its core.
  • Embracing the distinctive "Opposites United" design language, the Carnival confidently embodies a modern and bold appearance befitting of an SUV.
  • An available wide and contoured skid plate contrasts against the black cladding on the lower rear fascia completes the exterior redesign.
  • 2 Kia Digital Key requires an eligible Kia Connect subscription and a compatible smart device with an active data plan.

NEW 2025 KIA K5 MAKES NORTH AMERICAN DEBUT AT CHICAGO AUTO SHOW

Retrieved on: 
Thursday, February 8, 2024

IRVINE, Calif., Feb. 8, 2024 /PRNewswire/ -- Kia America chose the concrete corridors of Chicago to pull the wraps off the refreshed 2025 K5 midsize sedan today at the opening of the Chicago Auto Show. The show played host to the sporty sedan's North American debut, which features a new-for-K5 2.5-liter normally aspirated engine, updated design cues inside and out, drivetrain refinements and numerous tech upgrades across five trim levels: LXS, EX, GT-Line (in front or all-wheel drive) and the hot-blooded turbocharged GT.

Key Points: 
  • The updates for 2025 position the K5 in the sweet spot for those needing room for five but prefer to make a bold statement when it comes to their vehicle."
  • For the 2025 model year, subtle refinements highlight more standard features across the lineup with a focus on the popular EX trim.
  • Digital Key 22, heated steering wheel, and power folding mirrors with integrated LED turn signals are all standard.
  • Already a standout in the midsize sedan segment, the 2025 Kia K5's design enhancements better align with Kia's Opposites United typography.

IPC and the PCBAA Urge Congress to Fully Fund Printed Circuit Boards or Face Continuing National Security and Economic Risks

Retrieved on: 
Wednesday, February 7, 2024

These funding sources are crucial to restore American leadership in the strategically vital printed circuit board (PCB) industry.

Key Points: 
  • These funding sources are crucial to restore American leadership in the strategically vital printed circuit board (PCB) industry.
  • The United States currently produces only four percent of the world’s supply compared to 30 percent at the turn of the century.
  • IPC and our member companies urge Congress to reinvigorate a domestic PCB industry that is critical to U.S. industrial resiliency, economic competitiveness, and national security.
  • For more information about printed circuit boards, microelectronics and electronics manufacturing contact:
    Printed Circuit Board Association of America: Mike Doble – [email protected] (703) 579-7963

ASC24 Student Supercomputer Challenge: Twenty-five University Teams Worldwide Advance to the Finals

Retrieved on: 
Wednesday, February 7, 2024

Over 300 universities worldwide participated, with twenty-five standout teams advancing to the finals.

Key Points: 
  • Over 300 universities worldwide participated, with twenty-five standout teams advancing to the finals.
  • Among the finalists are renowned institutions such as Huazhong University of Science and Technology, Peking University, the Chinese University of Hong Kong, National Tsing Hua University, Friedrich-Alexander-University Erlangen-Nuremberg, and the National University of Cordoba.
  • The ASC24 finals feature a lineup of traditional powerhouses, including Peking University - the champion of the 10th ASC onsite finals; the Chinese University of Hong Kong - the champion of the 10th ASC virtual finals; University of Science and Technology of China; Shanghai Jiao Tong University; and Friedrich-Alexander-University Erlangen-Nuremberg.
  • Additionally, there is great excitement surrounding the debut of teams from National University of Cordoba, Macau University of Science and Technology, and Southwest Petroleum University, marking their first appearance in the ASC finals this year.

MITRE CTO Charles Clancy Testifies on Enhancing Resilience of Critical Infrastructure at Congressional Homeland Security Subcommittee Hearing on Securing Operational Technology Within the Water Sector in the Interest of National Security

Retrieved on: 
Tuesday, February 6, 2024

“The threat has escalated dramatically,” said Charles Clancy , Ph.D., senior vice president and chief technology officer (CTO), MITRE.

Key Points: 
  • “The threat has escalated dramatically,” said Charles Clancy , Ph.D., senior vice president and chief technology officer (CTO), MITRE.
  • “The scale of the threat requires critical infrastructure operators to prepare and respond more like they would to a major natural disaster.
  • To learn more about MITRE’s independent work in securing critical infrastructure, visit mitre.org/cipic .
  • Written testimony is available on request at [email protected] or download the testimonies of all hearing witnesses at https://homeland.house.gov/wp-content/uploads/2024/02/2024-02-06-CIP-HRG... .

HIGHWAY HOLDINGS REPORTS FISCAL 2024 THIRD QUARTER AND NINE MONTH RESULTS; THIRD QUARTER SALES INCREASE 60% YEAR OVER YEAR

Retrieved on: 
Thursday, February 1, 2024

Net sales for the third quarter of fiscal year 2024 increased 60% to $4.1 million compared with $2.6 million in the year ago period.

Key Points: 
  • Net sales for the third quarter of fiscal year 2024 increased 60% to $4.1 million compared with $2.6 million in the year ago period.
  • Net sales for the first nine months of fiscal year 2024 were $6.8 million, compared with $8.5 million in the year ago period.
  • Revenue in the first nine months of fiscal year 2024 was significantly impacted by the COVID boom and post-COVID bust cycle on Highway Holdings' customers.
  • Synova serves as an all-encompassing OEM manufacturer, with a comparable technological proficiency and a parallel business approach with Highway Holdings.

Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World

Retrieved on: 
Thursday, January 25, 2024

Jiangsu Alphamab will be responsible of manufacturing KN035 within and outside the Territory.

Key Points: 
  • Jiangsu Alphamab will be responsible of manufacturing KN035 within and outside the Territory.
  • 3D Medicines retains the right to develop and commercialize Envafolimab for any purpose outside the Territory.
  • Under the terms of the agreement, GSSA will receive from Jiangsu Alphamab and 3D Medicines, an exclusive license to develop, register, commercialize, Envafolimab for the oncology indication in the Territory.
  • The Licensors' respective entitlement to the payments (including the upfront payment, milestone payment and the royalty fees) under the License Agreement are subject to the agreements between 3D Medicines and Jiangsu Alphamab.

Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World

Retrieved on: 
Thursday, January 25, 2024

Jiangsu Alphamab will be responsible of manufacturing KN035 within and outside the Territory.

Key Points: 
  • Jiangsu Alphamab will be responsible of manufacturing KN035 within and outside the Territory.
  • 3D Medicines retains the right to develop and commercialize Envafolimab for any purpose outside the Territory.
  • Under the terms of the agreement, GSSA will receive from Jiangsu Alphamab and 3D Medicines, an exclusive license to develop, register, commercialize, Envafolimab for the oncology indication in the Territory.
  • The Licensors' respective entitlement to the payments (including the upfront payment, milestone payment and the royalty fees) under the License Agreement are subject to the agreements between 3D Medicines and Jiangsu Alphamab.